Please ensure Javascript is enabled for purposes of website accessibility

Trulieve Cannabis Dips 1.6% on Mixed Q1

By Eric Volkman - May 13, 2021 at 7:18PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Still, it managed that rarest of all things for marijuana companies: a net profit.

Trulieve Cannabis (TCNNF -2.05%) was again in the marijuana-stock spotlight on Thursday. This time, it was because of the company's latest quarterly results rather than any splashy acquisition.

Trulieve's first quarter, the results of which were published in the morning, show that the Florida-based multistate operator (MSO) booked revenue of $193.8 million; this was 15% higher that the preceding quarter, slightly more than double the year-ago tally, and a new quarterly record for the company.

And in a rare development for a marijuana operator (but not necessarily for Trulieve), the company earned a profit: $30.1 million, or $0.24 per diluted share. That was more than tenfold the previous quarter's net profit, and 27% higher than the year-ago period.

Marijuana leaf atop a $100 bill.

Image source: Getty Images.

The headline numbers represented a good news/bad news situation; Yahoo! Finance data shows that on average, analysts were estimating just $189.8 million for revenue, but $0.26 per share for net profit.

Trulieve's continued success as a dominant and ever-growing player in its native market, and its fairly assertive expansion, were the catalysts behind those hefty growth numbers.

The latter activity is kicking into high gear with the company's recently announced acquisition of Arizona-based peer Harvest Health & Recreation. That deal, which is to be consummated entirely in stock, is valued at $2.1 billion. Once it closes, it will instantly make Trulieve a powerful MSO with a presence on both U.S. coasts.

But it seems that investors were expecting better of the cannabis highflier. On Thursday, they traded its stock down by 1.6%, which contrasted with the S&P 500's 1.2% gain.


Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Trulieve Cannabis Stock Quote
Trulieve Cannabis
$12.88 (-2.05%) $0.27

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.